GEMMA Biotherapeutics
PrivateLast Round
Grant
Jul 9, 2026
Total Funding Raised
$34M
Company Overview
GEMMA Biotherapeutics is a biotechnology company that develops gene therapies for rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GEMMA Biotherapeutics Comparables
Compare GEMMA Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iECURE | 81% | |
| Capsida Biotherapeutics | 81% | |
| Passage Bio | 79% | |
GEMMA Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 9, 2026 | ||||
| Seed | Dec 23, 2024 | ||||
| Strategic | Oct 8, 2024 |
Key People
Founding team and executive leadership
GEMMA Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bioluminescence Ventures | Seed |
| ARPA-H | Grant |
| Earlybird Venture Capital | Seed |
| Double Point Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Affiliation with Franklin Biolabs to translate scientific work into clinical trials.
- Mar 1, 2026
Gene therapy pioneer Jim Wilson appointed to lead the company.
GEMMA Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GEMMA Biotherapeutics's valuation, stock price, and market status.